Skip to content
Wearables & measurementCohort study4 min read

A weak day-night activity rhythm on a wrist tracker linked to higher heart disease risk

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Accelerometer-Derived Rest-Activity Rhythm Amplitude, Genetic Predisposition, and the Risk of Ischemic Heart Disease: Observational and Mendelian Randomization Study. · Journal of medical Internet research · 2025 · Original paper ↗

Key takeaway

Among 84,095 UK Biobank participants followed for a median of 7.90 years, those in the lowest quintile of rest-activity rhythm amplitude had a higher hazard of ischemic heart disease (HR 1.20, 95% CI 1.12-1.30). The wrist-device data and genetic analyses suggest a causal link, but Mendelian randomization depends on assumptions, and its result was borderline (P=.047).

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

A strong daily rhythm of rest at night and activity by day may protect health, but whether its amplitude affects ischemic heart disease (IHD), and whether genetic risk changes that link, was unclear. The authors combined an observational cohort with Mendelian randomization to test causality and the role of genetic predisposition.

Who and how

Prospective cohort in the UK Biobank among people with no prior IHD who wore a wrist accelerometer between 2013 and 2015 for at least 7 days. Rest-activity rhythm amplitude (RARA) was derived nonparametrically, and disrupted RARA was defined as the lowest quintile. Incident IHD (ICD-10 codes I20-25) came from medical records, and genetic risk was grouped by IHD polygenic risk score (lowest quartile, middle two quartiles, highest quartile). Cox proportional hazards models tested associations and interactions. A 2-sample Mendelian randomization used RARA genome-wide data from UK Biobank and IHD data from FinnGen, with the inverse-variance weighted method and several sensitivity methods.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Of 84,095 participants followed for a median of 7.90 years (IQR 7.33-8.41), 3870 (4.60%) developed IHD. Disrupted RARA was associated with higher IHD risk (HR 1.20, 95% CI 1.12-1.30; P=.002).
  2. 2
    Genetic predisposition did not significantly modify this link on the multiplicative scale (HR 0.92, 95% CI 0.76-1.11; P=.39 and HR 0.91, 95% CI 0.74-1.12; P=.37), and results were consistent on the additive scale.
  3. 3
    Compared with high RARA and low genetic risk, disrupted RARA with high genetic risk had the highest IHD risk (HR 2.63, 95% CI 2.29-3.02; P<.001); disrupted RARA with low genetic risk had the smallest increase (HR 1.29, 95% CI 1.10-1.52; P<.001).
  4. 4
    Mendelian randomization supported the observational result (OR 1.13, 95% CI 1.00-1.28; P=.047) and was robust in sensitivity analyses.

Limits & uncertainty

  1. 1
    The Mendelian randomization estimate is borderline (95% CI 1.00-1.28), so evidence for causation is modest, and the method rests on assumptions about the genetic variants.
  2. 2
    UK Biobank participants wore the device for about a week and are generally healthier than the population, so one week may not reflect long-term rhythm.
  3. 3
    Observational links can be confounded by lifestyle and health factors; the abstract does not list the adjustments.
  4. 4
    The abstract says nothing about whether the findings apply beyond the studied population. This reading rests on the abstract only.

What to take from it

Having a clear contrast between an active day and a restful night is associated with lower heart disease risk, and the pattern held across genetic risk levels. The study does not show that changing your rhythm will lower your risk. Heart disease prevention decisions belong with your clinician.

Reading your own data

Wrist trackers can show how active your days are compared with how still your nights are, though most apps do not show the exact amplitude measure used here. Use the same device and compare your own weeks, looking at whether daytime activity and night rest become more distinct over time.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

The rest-activity rhythm amplitude (RARA), as a fundamental human behavior, has been linked to various health conditions. However, its causal relationship with ischemic heart disease (IHD), along with the potential modification by genetic predisposition, remains unclear.

Objective

This study aimed to investigate the causal association between RARA and IHD using a triangulation approach that incorporated both observational and Mendelian randomization (MR) analyses, and to determine whether genetic predisposition modifies this relationship.

Methods

First, a prospective cohort analysis was conducted among individuals who had no history of IHD before wearing wrist actigraphy between 2013 and 2015 in the UK Biobank. RARA was derived nonparametrically from accelerometer data worn for at least 7 days. Disrupted RARA was established as the lowest quintile of accelerometer-derived amplitude. Incident IHD was identified through medical records using ICD-10 (International Statistical Classification of Diseases, Tenth Revision) codes I20-25. Genetic predisposition was assessed with polygenic risk scores for IHD (IHD-PRS), which were categorized into "low IHD-PRS" (lowest quartile), "intermediate IHD-PRS" (second and third quartiles), and "high IHD-PRS" (highest quartile). Cox proportional hazards models were used to assess the association between RARA and incident IHD, as well as the modification effects of IHD-PRS. Second, we obtained RARA genome-wide association study data from the UK Biobank and IHD genome-wide association study data from FinnGen. A 2-sample MR using inverse-variance weighted methods was performed to examine the causality between them. Several other well-established methods, including random-effects and radial inverse-variance weighted method, Mendelian randomization pleiotropy residual sum and outlier, and maximum likelihood, were also performed for sensitivity analyses.

Results

A total of 84,095 participants were followed up for a median of 7.90 (IQR 7.33-8.41) years. Overall, 3870 (4.60%) individuals developed IHD. Disrupted RARA was significantly associated with a higher risk of IHD (hazard ratio [HR] 1.20, 95% CI 1.12-1.30; P=.002). No significant modification effects by genetic predisposition on the multiplicative scale were found for this association (HR 0.92, 95% CI 0.76-1.11; P=.39 and HR 0.91, 95% CI 0.74-1.12; P=.37, respectively). The results remained consistent when we used the additive interaction scale to assess effect modification. Compared with participants with high RARA and low IHD-PRS (reference), those with disrupted RARA and high IHD-PRS had the highest risk of IHD (HR 2.63, 95% CI 2.29-3.02; P<.001), while those with disrupted RARA and low IHD-PRS had the smallest increased risk (HR 1.29, 95% CI 1.10-1.52; P<.001). The remaining groups showed intermediate risks in ascending order. MR results supported the observational findings (odds ratio [OR] 1.13, 95% CI 1.00-1.28; P=.047). This association was robust in our sensitivity MR analyses.

Conclusions

The study suggests a potential causal relationship between RARA and IHD, independent of genetic predisposition, highlighting the significance of RARA for IHD prevention.

Sources & attribution

Accelerometer-Derived Rest-Activity Rhythm Amplitude, Genetic Predisposition, and the Risk of Ischemic Heart Disease: Observational and Mendelian Randomization Study.

Wang L, Zhang J, Xiao X, Tang X, Tang J, Xu H, Guo B, Zhao X.

Journal of medical Internet research · 2025-12-15

DOI: 10.2196/79301 ↗PubMed · 41397692 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →